郑明志,胡彩容,程燕铭.半弧和剪刀形切线弧技术在左侧乳腺癌根治术后放疗中的剂量学研究[J].肿瘤学杂志,2018,24(5):470-475.
半弧和剪刀形切线弧技术在左侧乳腺癌根治术后放疗中的剂量学研究
Dosimetric Comparison of Semi-arc and Tangent-arc Techniques in Volumetric Modulated Arc Therapy for Left Breast Cancer
投稿时间:2017-07-19  
DOI:10.11735/j.issn.1671-170X.2018.05.B012
中文关键词:  乳腺肿瘤  半弧  切线弧  剂量学
英文关键词:breast neoplasm  semi-arc  tangent-arc  dosimetric
基金项目:福建省医学创新课题(2014-CXB-5);2013-2014年度国家临床重点专科建设项目(国卫办医函[2013]544号);福建省2012年临床重点专科(西医类别)建设项目(闽卫科教[2012]149号)
作者单位
郑明志 福建省肿瘤医院福建医科大学附属肿瘤医院 
胡彩容 福建省肿瘤医院福建医科大学附属肿瘤医院 
程燕铭 福建省肿瘤医院福建医科大学附属肿瘤医院 
摘要点击次数: 1822
全文下载次数: 571
中文摘要:
      摘 要:[目的] 探讨半弧(semi-arc,SA)和剪刀形切线弧(tangent-arc,TA)技术在左侧乳腺癌根治术后放疗中的应用研究及剂量学优势。[方法] 选取15例根治术后的左侧乳腺癌病例,在Monaco计划系统上分别采用SA和TA两组射野方式进行容积旋转调强(VMAT)计划设计,比较两组计划的靶区平均剂量、最大剂量、适形性指数(HI)、均匀性指数(CI)等,以及危及器官(OAR)的相关受照剂量体积参数。[结果] 对于胸壁靶区PTV-T,TA射野组的Dmean和D2均小于SA组(P<0.05),且HI和CI值优于SA组;对于锁骨淋巴结靶区PTV-N,虽然在HI和CI上两组差异无统计学意义,但Dmean、D98和D2均呈现TA
英文摘要:
      Abstract:[Objective] To compare the dosimetry advantage of semi-arc(SA) and forficiform tangent-arc(TA) techniques in volumetric modulated arc therapy(VMAT) for the left breast cancer after radical operation. [Methods] For 15 postoperative patients with left breast cancer,SA and TA beam fields for VMAT plans were designed on Monaco plan system,respectively. The mean dose,maximum dose,homogeneity index(HI) and conformity index(CI) of the targets were compared. The corresponding radiation doses of organs at risk(OAR) were also compared. [Results] For chest wall target PTV-T,the Dmean and D2 of TA group were less than those of SA(P<0.05),HI and CI were better than SA. For clavicle lymph node target PTV-N,the HI and CI of two groups had no significant difference,but the Dmean,D98 and D2 of TA were significantly lower than those of SA(P<0.05). For the OARs,the V5,V10 and Dmean of contralateral lung in TA group were significantly reduced,and better than those in SA group(P<0.05),and further protected the heart,spinal cord,the contralateral breast and the left head of the humerus. [Conclusion] Two beam modalities can meet the requirements of clinical application with VMAT plan for breast cancer,but under the premise of the same target coverage,the mean dose,maximum dose,HI,CI in TA group can further protect OARs,it was more suitable for the left breast cancer in VMAT.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器